Medical history screening for thrombophilic risk: Is this adequate?

Fertility and Sterility

Volumn 95, Issue 6, 2011, Pages 1917-1921

  Eggert Kruse, Waltraud ^a   Ziegler, Andrea ^a   Horlbeck, Sandra ^a   Strowitzki, Thomas ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

APC resistance screening; blood coagulation; factor V Leiden mutation; hormone replacement therapy; thromboembolic risk factors; thromboembolism

Indexed keywords

ACTIVATED PROTEIN C; BLOOD CLOTTING FACTOR 5 LEIDEN;

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; CARDIOVASCULAR RISK; ENDOCRINE DISEASE; FAMILY HISTORY; FEMALE; GENE MUTATION; GENOTYPE; HORMONAL THERAPY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MASS SCREENING; MEDICAL HISTORY; PRIORITY JOURNAL; RELIABILITY; THROMBOEMBOLISM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DIAGNOSTIC TECHNIQUES, OBSTETRICAL AND GYNECOLOGICAL; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMANS; MASS SCREENING; MEDICAL HISTORY TAKING; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; RISK FACTORS; THROMBOPHILIA; YOUNG ADULT;

EID: 79954986220     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2011.02.053     Document Type: Article

References (69)

1. F.R. Rosendaal Venous thrombosis: a multicausal disease Lancet 353 1999 1167 1173 (Pubitemid 29155221)
2. E.J. Favaloro, D. McDonald, and G. Lippi Laboratory investigation of thrombophilia: the good, the bad, and the ugly Semin Thromb Hemost 35 2009 695 710
3. J.A. Heit, M.D. Silverstein, and D.N. Mohr Predictors of survival after deep vein thrombosis and pulmonary embolism Arch Intern Med 159 1999 445 453 (Pubitemid 29108909)
4. F.A. Anderson, H.B. Wheeler, and R.J. Goldberg A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism Arch Intern Med 151 1991 933 938
5. A. Marchiori, L. Mosena, M.H. Prins, and P. Prandori The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies Haematologica 92 2007 1107 1114 (Pubitemid 350144218)
6. V. De Stefano, I. Martinelli, P.M. Mannucci, K. Paciaroni, P. Chiusolo, and I. Casorelli The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation N Engl J Med 341 1999 801 806 (Pubitemid 29420475)
7. M. Canonico, G. Plu-Bureau, G.D.O. Lowe, and P.Y. Scarabin Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis Br Med J (BMJ) 336 2008 1227 1231 (Pubitemid 351809317)
8. N. Botto, S. Maffei, S. Manfredi, M.G. Colombo, A.M. Mazzone, and M.G. Andreassi Prothrombotic mutations, family history and the risk of thrombosis in postmenopausal women: implications for hormone replacement therapy Climacteric 13 2011 25 30
9. J.P. Vandenbroucke, T. Koster, E. Briet, P.H. Reitsma, R.M. Bertina, and F.R. Rosendaal Increased risk of venous thrombosis in oral contraceptive users who are carriers of factor V Leiden mutation Lancet 344 1994 1453 1457 (Pubitemid 24351698)
10. O. Wu Postmenopausal hormone replacement therapy and venous thromboembolism Gend Med 2 2005 518 527
11. O. Wu, L. Robertson, P. Langhorne, S. Twaddle, G.D.O. Lowe, and P. Clark Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review Thromb Haemost 94 2005 17 25
12. C. Straczek, E. Oger, Yon de Jonage Beau, M. Canonico, G. Plu-Bureau, and J. Conard Prothrombotic mutations, hormone therapy and venous thromboembolism among postmenopausal women Circulation 112 2005 3495 3500
13. R.E. Peverill Hormone therapy and venous thromboembolism Best Pract Res Clin Endocrin Metabolism 17 2003 149 164
14. K.W.M. Bloemenkamp, F.M. Helmerhorst, F.R. Rosendaal, and J.P. Vandenbroucke Thrombophilias and gynecology Best Pract Res Clin Obstet Gynecol 17 2003 509 528
15. J.A. Steward, P.J. Hamilton, and A.P. Murdoch Thromboembolic disease associated with ovarian stimulation and assisted conception techniques Hum Reprod 12 1997 2167 2173 (Pubitemid 27494024)
16. K.E. Brummel-Ziedins, M. Gissel, C. Francis, J. Queenan, and K.G. Mann The effect of high circulating estradiol levels on thrombin generation during in vitro fertilization Thromb Res 12 2009 505 507
17. J. Curvers, A.W. Nap, M.C. Thomassen, S.J. Nienhus, K. Hamulyak, and J.L. Evers Effect of in vitro fertilization treatment and subsequent pregnancy on the protein C pathway Br J Haematol 115 2001 400 407 (Pubitemid 34203509)
18. T. Buchholz, and C.J. Thaler Inherited thrombophilia: impact on human reproduction Am J Reprod Immunol 50 2003 20 32 (Pubitemid 36805761)
19. G. Norrie, R.G. Farquharson, and M. Greaves Screening and treatment for heritable thrombophilia in pregnancy failure: inconsistencies among UK early pregnancy units Br J Haemotol 144 2009 241 244
20. P. Clark, I.D. Walker, P. Langhorne, L. Crichtlon, A. Thomson, and M. Greaves SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage Blood 115 2010 4162 4167
21. P.G. Lindquist, P.J. Svensson, K. Marsal, L. Grennert, M. Lutherkort, and B. Dahlbäck Activated protein C resistance (FV:Q506) and pregnancy Throm Haemost 81 1999 532 537 (Pubitemid 29178936)
22. W.H. Kutteh, and D.A. Triplett Thrombophilias and recurrent pregnancy loss Semin Reprod Med 24 2006 54 65 (Pubitemid 43132675)
23. J.R. Meinhardi, S. Middledorp, P.J. Kam, M.M.W. Koopman, E.C.M. van Pampus, and K. Hamulyak Increased risk for fetal loss in carriers of the factor V Leiden mutation Ann Intern Med 130 1999 736 739 (Pubitemid 29211511)
24. G. Sarig, J.S. Younis, R. Hoffman, N. Lanir, Z. Blumenfeld, and B. Brenner Thrombophilia is common in women with idiopathic pregnancy loss and is associated with late pregnancy wastage Fertil Steril 77 2002 342 347 (Pubitemid 34086913)
25. A.M. Cumming, R.C. Tait, S. Fildes, and C.R. Hay Diagnosis of APC resistance during pregnancy Br J Haematol 92 1996 1026 1029
26. E. Rey, S.R. Kahn, M. David, and I. Shrier Thrombophilic disorders and fetal loss: a meta-analysis Lancet 361 2003 901 908 (Pubitemid 36335814)
27. B. Dahlbäck, and B. Hildebrand Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V Proc Natl Acad Sci USA 91 1994 1396 1400 (Pubitemid 24059018)
28. B. Dahlbäck Resistance to activated protein C, the Arg 506 to Gln mutation in the factor V gene, and venous thrombosis. Functional tests and DNA-based assays, pros and cons Thromb Haemost 73 1995 739 742
29. P.J. Svensson, and B. Dahlbäck Resistance to activated protein C as a basis for venous thrombosis N Engl J Med 330 1994 517 522 (Pubitemid 24058953)
30. B. Dahlbäck Resistance to activated protein C caused by the Factor V R506Q mutation is a common risk factor for venous thrombosis Thromb Haemost 78 1997 483 488 (Pubitemid 27289289)
31. B. Dahlbäck Activated protein C resistance and thrombosis: molecular mechanisms of hypercoagulable state due to FV506Q mutations Semin Thromb Hemost 25 1999 273 289 (Pubitemid 29357748)
32. B. Dahlbäck The discovery of activated protein C resistance J Thromb Haemost 1 2003 3 9
33. T. Koster, F.R. Rosendaal, H. de Ronde, E. Briet, J.P. Vandenbroucke, and R.M. Bertina Venous thrombosis due to poor anticoagulant response to activated protein C. Leiden Thrombophilia Study Lancet 342 1993 1503 1506 (Pubitemid 23362165)
34. R.M. Bertina, B.P. Koeleman, T. Koster, F.R. Rosendaal, R.J. Dirven, and H. de Ronde Mutation in blood coagulation factor V associated with resistance to activated protein C Nature 369 1994 64 67 (Pubitemid 24144355)
35. B. Zöller, and B. Dahlbäck Linkage between inherited resistance to activated protein C and factor V gene mutation in venous thrombosis Lancet 343 1994 1536 1538 (Pubitemid 24180052)
36. B. Zöller, P.J. Svensson, X. He, and B. Dahlbäck Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C J Clin Invest 94 1995 2521 2524
37. D.T. Price, and P.M. Ridker Factor V Leiden mutation and the risk for thromboembolic disease: a clinical perspective Ann Intern Med 127 1997 895 903 (Pubitemid 27490627)
38. R. Lee, N.M. Kaplan, and B.F. Palmer Factor V Leiden: a clinical review Am J Med Sci 322 2001 88 102
39. H. Jick, L.E. Derby, M.W. Myers, C. Vasilakis, and K.M. Newton Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens Lancet 348 1996 981 983 (Pubitemid 26340752)
40. PEPI (The postmenopausal estrogen/progestin interventions trial) writing group Effects of estrogen/progestin regimen on heart disease risk factors in postmenopausal women JAMA 273 1995 199 200
41. B.T. Heijmans, R.G. Westendorp, and D.L. Knook The risk of mortality and the factor V Leiden mutation in a population-based cohort Thromb Haemost 80 1998 607 609 (Pubitemid 28479348)
42. F.R. Rosendaal, M. Vessey, A. Rumley, E. Daly, M. Woodward, and F.M. Helmerhorst Hormone replacement therapy, postthrombotic mutations and the risk of VTE Br J Haematol 116 2002 851 854 (Pubitemid 34227006)
43. E. Daly, M.P. Vessey, M.M. Hawkins, J.L. Carson, P. Gough, and S. Marsh Case control study of venous thromboembolism risk in users of hormone replacement therapy Lancet 348 1996 977 980 (Pubitemid 26340751)
44. P.G. Lindquist, and B. Dahlbäck Reactions to awareness of activated protein C resistance carriership: a descriptive study of 270 women Acta Obstet Gynecol Scand 82 2003 467 470 (Pubitemid 36629855)
45. D.C. Rees, and M. Cox World distribution of factor V Leiden Lancet 346 1995 1133 1134
46. P.M. Ridker, J.P. Miletich, and C.H. Hennekens Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening JAMA 277 1997 1305 1307 (Pubitemid 27194355)
47. M. Greaves Pathogenesis and management of antiphospholipid syndrome Thromb Res 123 2009 54 59
48. E. Norstroem, E. Thorelli, and B. Dahlbäck Functional characterization of recombinant FV Cambridge and FV Hong Kong Blood 100 2002 524 530 (Pubitemid 34761115)
49. M. Steen, E.A. Norstroem, and A.L. Tholander Functional characterization of Factor V lle359Thr: a novel mutation associated with thrombosis Blood 103 2004 3381 3387 (Pubitemid 38525668)
50. R. Liang, C.K. Lee, and M.S. Wat Clinical significance of Arg 306 of factor V gene Blood 92 1998 2599 2600 (Pubitemid 28453010)
51. H.C.M. de Visser, F.R. Rosendaal, and R.M. Bertina A reduced sensitivity for activated protein C in the absence of factor V Leiden mutation increases the risk of venous thrombosis Blood 93 1999 1271 1276 (Pubitemid 29076142)
52. F. Rodeghiero, and A. Tosetto Activated protein C resistance and Factor V Leiden mutation are independent risk factors for venous thromboembolism Ann Intern Med 130 1999 643 650 (Pubitemid 29196198)
53. C. Legnani, M. Cini, B. Cosmi, S. Mattarozzi, Manto Lo, and G. Palareti Oral contraceptive use in women with anticoagulant response to activated protein C but not carrying the factor V Leiden mutation increases the risk of venous thrombosis Thromb Heamost 91 2004 712 718 (Pubitemid 38477451)
54. EGAPP Working Group Recommendations from the EGAPP Working Group: routine testing for factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members Genet Med 13 2011 67 76
55. R.S. Kristensen, K. Andersen-Ramberg, L. Bathum, and B. Jeune Factor V Leiden and venous thrombosis in Danish centenarians Throm Haemost 80 1998 860 861 (Pubitemid 28521736)
56. W.M. Jordan Pulmonary embolism Lancet 2 1962 1146 1147
57. L.E. Bottiger, G. Boman, and G. Eklund Oral contraceptives and thromboembolic disease: effects of lowering oestrogen content Lancet 1 1980 1097 1101 (Pubitemid 10100362)
58. F.M. Helmerhorst, K.W. Bloemenkamp, and F.R. Rosendaal Oral contraceptives and thrombotic disease: risk of venous thromboembolism Thromb Haemost 78 1997 327 333 (Pubitemid 27289262)
59. J.M. Kemmeren, A. Algra, J.C.M. Meijers, B.N. Bouma, and D.E. Grobee Effects of second and third generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation Blood Coagul Fibrinol 13 2002 373 381 (Pubitemid 35001853)
60. G. Lowe, M. Woodward, M. Vessey, A. Rumley, P. Gough, and E. Daly Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years: relationship to hormone replacement therapy Thromb Haemost 83 2000 530 535 (Pubitemid 30201125)
61. M. Cushman, A.W. Tsai, R.H. White, S.R. Heckbert, W.D. Rosamenod, and P. Enright Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology Am J Med 117 2004 19 25 (Pubitemid 38801482)
62. J. Curvers, M. Christella, G.D. Thomassen, J. Rimmer, K. Hamulyak, and J. van der Meer Effects of hereditary and acquired risk factors of venous thrombosis on a thrombin generation-based APC resistance test Throm Haemost 88 2002 5 11 (Pubitemid 34752259)
63. D.M. Herrington, E. Vittinghoff, T.D. Howard, D.A. Major, J. Owen, and D.M. Reboussin Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease Arterioscler Thromb Vasc Biol 22 2002 1012 1017 (Pubitemid 34655232)
64. J. Bonnar, R. Green, and L. Norris Inherited thrombophilia and pregnancy: the obstetric perspective Semin Thromb Hemost 24 1998 49 53
65. Royal College of Obstetricians and Gynaecologists Guideline No. 19 Hormone replacement therapy and venous thromboembolism Royal College of Obstetricians and Gynaecologists (RCOG) Guideline No. 19 2004 1 9
66. B. Cosmi, C. Legnani, F. Bernardi, S. Coccheri, and Palareti Role of family history in identifying women with thrombophilia and higher risk of venous thromboembolism during oral contraception Arch Intern Med 163 2003 1105 1109 (Pubitemid 36548941)
67. S. Noboa, G. Le Gal, K. Lacut, B. Mercier, C. Leroyer, and E. Novak Family history as a risk factor for venous thromboembolism Thromb Res 122 2008 624 629
68. I.D. Bezemer, F.J.M. van der Meer, J.C.J. Eikenboom, F.R. Rosendaal, and C.J.M. Doggen The value of family history as a risk indicator for venous thrombosis Arch Intern Med 169 2009 610 615
69. J.B. Segal, D.J. Brotman, A.J. Necochea, and A. Emadi Predictive value of Factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation JAMA 301 2009 2472 2485